scholarly journals PND12 COST-EFFECTIVENESS OF RASAGILINE VERSUS ROPINIROLE EXTENDED RELEASE IN DELAYING LEVODOPA IN THE TREATMENT OF EARLY PARKINSON'S DISEASE IN THE UNITED STATES

2009 ◽  
Vol 12 (3) ◽  
pp. A192 ◽  
Author(s):  
R Farkouh ◽  
MR Wilson ◽  
ML Tarrants ◽  
J Castelli-Haley ◽  
C Armand
Keyword(s):  
United States ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Cost Effectiveness ◽  
Extended Release ◽  
The United States ◽  
Early Parkinson’S Disease

scholarly journals The long‐term direct and indirect economic burden among Parkinson's disease caregivers in the United States

2018 ◽  
Vol 34 (2) ◽  
pp. 236-245 ◽  
Author(s):  
Pablo Martinez‐Martin ◽  
Dendy Macaulay ◽  
Yash J. Jalundhwala ◽  
Fan Mu ◽  
Erika Ohashi ◽  
...  
Keyword(s):  
United States ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Economic Burden ◽  
The United States

Comparison of caregiver strain in Parkinson's disease between Yamagata, Japan, and Maryland, The United States

2013 ◽  
Vol 19 (6) ◽  
pp. 628-633 ◽  
Author(s):  
Haruko Tanji ◽  
Shingo Koyama ◽  
Manabu Wada ◽  
Toru Kawanami ◽  
Keiji Kurita ◽  
...  
Keyword(s):  
United States ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
The United States ◽  
Caregiver Strain

scholarly journals A Differential Item Functioning (DIF) Analysis of the Communicative Participation Item Bank (CPIB): Comparing Individuals With Parkinson's Disease From the United States and New Zealand

2014 ◽  
Vol 57 (1) ◽  
pp. 90-95 ◽  
Author(s):  
Carolyn Baylor ◽  
Megan J. McAuliffe ◽  
Louise E. Hughes ◽  
Kathryn Yorkston ◽  
Tim Anderson ◽  
...  
Keyword(s):  
United States ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
New Zealand ◽  
Differential Item Functioning ◽  
The United States ◽  
Item Bank ◽  
Self Report ◽  
Item Functioning ◽  
Communicative Participation

Purpose To examine the cross-cultural applicability of the Communicative Participation Item Bank (CPIB) through a comparison of respondents with Parkinson's disease (PD) from the United States and New Zealand. Method A total of 428 respondents—218 from the United States and 210 from New Zealand—completed the self-report CPIB and a series of demographic questions. Differential item functioning (DIF) analyses were conducted to examine whether response bias was present across the 2 groups. Results No items were identified as having statistically significant DIF across the U.S. and N.Z. cohorts. Conclusion The current CPIB items and scoring parameters are also suitable for use with respondents from New Zealand.

Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease

2010 ◽  
Vol 25 (15) ◽  
pp. 2542-2549 ◽  
Author(s):  
Robert A. Hauser ◽  
Anthony H.V. Schapira ◽  
Olivier Rascol ◽  
Paolo Barone ◽  
Yoshikuni Mizuno ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Extended Release ◽  
Double Blind ◽  
Once Daily ◽  
Early Parkinson’S Disease
Sign in / Sign up

Export Citation Format

Share Document